[Asia Economy Reporter Ji Yeon-jin] Hightech Pharm announced on the 3rd that its sales revenue last year increased by 18.07% compared to the previous year, reaching 74.4 billion KRW. Operating loss was 3 billion KRW, and net loss for the period was 2.8 billion KRW, decreasing by 31.65% and 31.78%, respectively.
The company will pay a cash dividend of 50 KRW per common share.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

